https://clinicaltrials.gov/ct2/show/NCT03895372?type=Intr&cond=Psoriasis&lupd_s=03%2F15%2F2019&lupd_d=14
Condition : Psoriasis
Interventions : Drug: PF-06826647 or Placebo; Drug: PF-06826647
Sponsor : Pfizer
Not yet recruiting
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
NCT03895372
Fri, 29 Mar 2019 12:00:00 EDT
Last Update Posted: 03/29/19 09:49AM